Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

IMRT

  • Open Access
    Moderately Hypofractionated Helical Tomotherapy for Prostate Cancer: Ten-year Experience of a Mono-institutional Series of 415 Patients
    SALVATORE COZZI, MARIA PAOLA RUGGIERI, EMANUELE ALÌ, SEBASTIANO FINOCCHI GHERSI, FEDERICA VIGO, MATTEO AUGUGLIARO, LUCIA GIACCHERINI, FEDERICO IORI, MASOUMEH NAJAFI, LILIA BARDOSCIA, ANDREA BOTTI, VALERIA TROJANI, PATRIZIA CIAMMELLA and CINZIA IOTTI
    In Vivo March 2023, 37 (2) 777-785; DOI: https://doi.org/10.21873/invivo.13141
  • You have access
    Moderately Hypofractionated Intensity-modulated Radiotherapy With a Simultaneous Integrated Boost for Locally Advanced Head and Neck Cancer – Do Modern Techniques Fulfil Their Promise?
    JÖRN WICHMANN, MARTIN DURISIN, ROBERT MICHAEL HERMANN, ROLAND MERTEN and HANS CHRISTIANSEN
    In Vivo September 2021, 35 (5) 2801-2808; DOI: https://doi.org/10.21873/invivo.12566
  • You have access
    Monte Carlo Modeling of the Agility MLC for IMRT and VMAT Calculations
    SHINGO OHIRA, HIDEKI TAKEGAWA, MASAYOSHI MIYAZAKI, MASAHIKO KOIZUMI and TERUKI TESHIMA
    In Vivo September 2020, 34 (5) 2371-2380; DOI: https://doi.org/10.21873/invivo.12050
  • You have access
    Lack of Relevant Haemogram Changes During Percutaneous Radiotherapy of Localised Prostate Cancer
    FELIX ZWICKER, BENEDICT SWARTMAN, PETER E. HUBER, KLAUS HERFARTH, JÜRGEN DEBUS and HENRIK HAUSWALD
    In Vivo May 2020, 34 (3) 1555-1563; DOI: https://doi.org/10.21873/invivo.11945
  • You have access
    Hypofractionated Intensity-modulated Radiotherapy for Intermediate- and High-risk Prostate Cancer: A Retrospective Study
    NOBUTERU KUBO, HIDEMASA KAWAMURA, TAKAHIRO OIKE, HIRO SATO, MOTOTARO IWANAGA, TATSUJI MIZUKAMI, AKIKO ADACHI, HIROSHI MATSUI, KAZUTO ITO, KAZUHIRO SUZUKI and TAKASHI NAKANO
    In Vivo July 2019, 33 (4) 1235-1241; DOI: https://doi.org/10.21873/invivo.11595
  • You have access
    Using Image-guided Intensity-modulated Radiotherapy on Patients With Head and Neck Soft-tissue Sarcoma
    KHALED ELSAYAD, DENISE STOCKMANN, MOHAMMED CHANNAOUI, SERGIU SCOBIOALA, ANETA GRAJDA, HENDRIK BERSSENBRÜGGE, SEBASTIAN HUSS, CHRISTOS MOUSTAKIS, UWE HAVERKAMP, JOHANNES KLEINHEINZ, GEORG LENZ, EVA WARDELMANN and HANS THEODOR EICH
    In Vivo July 2019, 33 (4) 1293-1300; DOI: https://doi.org/10.21873/invivo.11602
  • You have access
    Combined Chemoradiotherapy-induced Weight Loss Decreases Survival in Locally Advanced Non-small Cell Lung Cancer Patients
    YI-JUN KIM, CHANGHOON SONG, KEUN-YONG EOM, IN AH KIM and JAE-SUNG KIM
    In Vivo May 2019, 33 (3) 955-961; DOI: https://doi.org/10.21873/invivo.11564
In Vivo

© 2026 In Vivo

Powered by HighWire